NEONATAL FORMULARY. DRUG USE IN PREGNANCY AND THE FIRST YEAR OF LIFE. 8TH EDITION

NEONATAL FORMULARY. DRUG USE IN PREGNANCY AND THE FIRST YEAR OF LIFE. 8TH EDITION

Editorial:
OXFORD UNIVERSITY PRESS
Año de edición:
Materia
Pediatría
ISBN:
978-0-19-884078-7
Páginas:
992
N. de edición:
8
Idioma:
Inglés
Disponibilidad:
Disponible en 2-3 semanas

Descuento:

-5%

Antes:

68,00 €

Despues:

64,60 €

Part 1: Drug prescribing and drug administration
Terms, symbols, abbreviations, and units
Drug storage and administration
Drugs and the law
The care and use of intravascular lines
Minimising intravenous infusion and drug hazards
Excipients in Neonatal Medicinal Products
Patient Safety Initiatives
Writing a hospital prescription
Adverse reactions and overtreatment
Renal Failure
Body weight and surface area
Effects of therapeutic hypothermia on medications
Pharmacokinetics, pharmacodynamics and appropriate dosing
Part 2: Drug monographs
Part 3: Maternal medication and its effect on the baby
Introduction
Further reading
Maternal medication and the baby

Neonatal Formulary provides comprehensive guidance on the safe use of the drugs prescribed during pregnancy and commonly given to babies during labour and delivery, as well as during lactation and the first year of life. Treating the journey from pregnancy to parenthood as a continuous event, the new edition contains updated information on how the drugs affect both mother and baby.
The first part of the book focuses on drug storage, drug licensing, and drug prescribing. In addition, it explains to why the metabolism of drugs differs in premature and sick infants, and why the practice of extrapolating doses from adult studies is unsafe. Patient safety, excipients, and therapies that affect drugs are also covered.
Part 2 consists of monographs for over 250 drugs that may find use in the neonatal unit, and possibly outside it. Each monograph is divided into sections covering use, pharmacology, treatment, drug interactions or other administration, information, supply and administration, and references. The monographs are evidence-based and include links to the Cochrane Database of Systematic Reviews, and national guidelines.
The third part presents information on additional drugs, and groups of drugs, that are often taken by mothers during pregnancy, labour, or during breast feeding. The drugs discussed in this section all affect the foetus or infant.

Containing far more detail than is available in the British National Formulary for Children, and with additional online material featuring updates related to specific drugs and dosing, Neonatal Formulary is an essential guide for neonatologists, neonatal nurses, hospital pharmacists, obstetric staff, advanced nurse practitioners and for all health care professionals caring for pregnant women and their infants in the first year of life.

Features
• Bringing together a mix of pharmacological and clinical knowledge, Neonatal Formulary is an essential resource for the neonatal and paediatric ward
• This book covers the period from conception through pregnancy and beyond with effects of administration of medicines to both mother and baby
• The drug monographs are up-to-date, extensively referenced and linked to the Cochrane Database of Systematic Reviews to provide evidence-based use of medicines
• This unique title details the effects of excipients (i.e. the forgotten ingredients in medicines) which can have the potential for harm in the young or premature baby
• Online material that is continuoulsy updated complements the print edition, making this title a living resource that presents the latest research in the field

NEW TO THIS EDITION:
• This new edition has expanded the numbers of drugs covered and also incorporated newer techniques for administration e.g. surfactants being given to spontaneously breathing babies using minimally invasive techniques
• New analytical techniques are now allowing a greater analysis of the pharmacokinetics of medicines in young and premature infants that previously was not available. These allow optimisation of the dosing regimens, maximising benefit whilst reducing risks.